Clinical trials and drug cost savings for Italian health service.

Francesca D'AmbrosioGianfranco De FeoGerardo BottiArturo CapassoSandro PignataPiera MaiolinoMaria TriassiAntonio NardoneFranco PerroneMichela PiezzoAntonio Maria GrimaldiIda PalazzoImmacolata De StasioRoberta D'AnielloAlessandro Morabito Giacomo Pascarella

Published in: BMC health services research (2020)

Clinical trials with investigational antineoplastic drugs provided free of charge by Sponsors render considerable cost savings, with a tangible benefit in clinical and administrative strategies to reduce drug expenditures.

Keyphrases

clinical trial
phase ii
drug induced
adverse drug
open label
health insurance
double blind
emergency department
randomized controlled trial
phase iii
electronic health record